GNQ Insilico

About GNQ Insilico

GNQ Insilico is a California-based company advancing precision medicine by integrating genomics, advanced computational science and quantum computing to accelerate drug discovery and development. It offers a genomics-driven platform that enables genomic stratification for cohort selection, in silico pharmacokinetics to predict safety and efficacy, and personalized drug design based on genomic profiles, along with genomic, epigenetic, and microbiome insights for diagnostics. The company emphasizes collaborations with major life sciences partners and aims to reduce development time and costs in the drug development lifecycle. Headquartered in Pleasanton, California, GNQ Insilico pursues scalable, privacy-conscious solutions for the life sciences and healthcare industries.